Huntington SF, de Nigris E, Puckett J, Kamal-Bahl S, et al. Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia. Leuk Lymphoma 2023 Oct 23:1-10. doi: 10.1080/10428194.2023.2256911.
PMID: 37870435